00:00
Treatment for hemophilia depends on
the type and the severity of the disorder.
00:05
Patients can actually
replace their clotting factor.
00:08
This can be done for a factors VIII and IX, and
this product comes from donated human blood
and you can also have a recombinant
clotting factor and this is made in a lab.
00:17
The good news is patients
can actually self infuse at home.
00:22
Another medication option is desmopressin which is
DDAVP and this can help stimulate factor VIII release.
00:30
A patient with hemophilia A can live a relatively
normal life when their condition is managed well
and they receive appropriate check-ups at a
comprehensive hemophilia treatment center.
00:39
But even with good hemophilia
care, complications can develop
and when they do, they usually
require immediate medical attention
since these complications
can be life threatening.
00:49
One is deep internal bleeding.
00:51
This is bleeding that can occur in the deep
muscle and can cause the limbs to swell.
00:55
The swelling compress on the
nerves and lead to numbness or pain.
00:59
The patient can also develop
hematuria or blood in the urine.
01:03
They may develop life-threatening
hemorrhages and this includes into the brain.
01:07
And remember the bleeding into
the joints, this is gonna cause damage.
01:10
It's gonna cause pain and arthritis
and eventual destruction of the joint.
01:14
This can also press on the nerves.
01:17
Another complication is severe
anemia due to the massive blood loss.
01:21
This can cause it's own
cascade of complications including
putting extra strain on the heart,
kidney and respiratory systems.
01:29
Infection is next.
01:30
Patients with hemophilia are more
likely to have blood transfusions
increasing the risk of receiving
contaminated blood products.
01:37
You can also have an adverse
reaction to the clotting factor treatment.
01:41
In some patients with hemophilia, the
immune system has a negative reaction
to these clotting factors
used to treat their bleeding.
01:48
When this happens, the immune system
develops proteins known as inhibitors
that inactivate the clotting factors
making the treatment less effective.